间歇性能量限制抑制转基因子宫内膜癌小鼠模型的肿瘤生长并增强紫杉醇反应
在高脂饮食诱导肥胖的Lkb1fl/flp53fl/fl子宫内膜癌小鼠模型中,间歇性能量限制(IER)与低脂饮食(LFD)均可减轻体重、逆转肥胖相关血清胰岛素、瘦素和炎症因子改变并减少肿瘤发生和质量,IER联合紫杉醇的肿瘤抑制效果最佳。
要点
- 高脂饮食肥胖小鼠切换至IER或LFD可降低体重并减少肿瘤发生和质量。
- IER较LFD更有效促进体重下降和抑制肥胖相关子宫内膜肿瘤生长。
- 紫杉醇在IER组中增强肿瘤抑制的获益最大。
核心结论
- 在Lkb1fl/flp53fl/fl小鼠中,IER在促进体重下降、抑制肥胖相关子宫内膜肿瘤生长(尤其联合紫杉醇)及逆转肥胖相关代谢不良效应方面通常比LFD更有效。
研究设计与样本
- Lkb1fl/flp53fl/fl小鼠分别喂食高脂饮食(HFD)或低脂饮食(LFD)以形成肥胖和瘦表型。
- 肥胖小鼠维持HFD或转换为LFD(HFD-LFD)或IER(HFD-IER);诱导子宫内膜癌10周后,每组接受紫杉醇或安慰剂4周。
主要发现
- HFD-IER和HFD-LFD相对于HFD降低体重,逆转肥胖诱导的血清胰岛素、瘦素和炎症因子改变,并降低肿瘤发生率和质量,常达到持续LFD相关水平。
- 紫杉醇与安慰剂相比在各组均增强肿瘤抑制,HFD-IER组获益最大。
- 各饮食方案产生不同的肿瘤基因表达和代谢谱,HFD-IER与更有利的抗肿瘤代谢和炎症环境相关。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Overweight/obesity is the strongest risk factor for endometrial cancer (EC), and weight management can reduce that risk and improve survival. We aimed to establish the differential benefits of intermittent energy restriction (IER) and low-fat diet (LFD), alone and in combination with paclitaxel, to reverse the procancer effects of high-fat diet (HFD)-induced obesity in a mouse model of EC. METHODS: Lkb1fl/flp53fl/fl mice were fed HFD or LFD to generate obese and lean phenotypes, respectively. Obese mice were maintained on a HFD or switched to a LFD (HFD-LFD) or IER (HFD-IER). Ten weeks after induction of endometrial cancer, mice in each group received paclitaxel or placebo for 4 weeks. Body and tumor weights; tumoral transcriptomic, metabolomic and oxylipin profiles; and serum metabolic hormones and chemocytokines were assessed. RESULTS: HFD-IER and HFD-LFD, relative to HFD, reduced body weight; reversed obesity-induced alterations in serum insulin, leptin and inflammatory factors; and decreased tumor incidence and mass, often to levels emulating those associated with continuous LFD. Concurrent paclitaxel, versus placebo, enhanced tumor suppression in each group, with greatest benefit in HFD-IER. The diets produced distinct tumoral gene expression and metabolic profiles, with HFD-IER associated with a more favorable (antitumor) metabolic and inflammatory environment. CONCLUSION: In Lkb1fl/flp53fl/fl mice, IER is generally more effective than LFD in promoting weight loss, inhibiting obesity-related endometrial tumor growth (particularly in combination with paclitaxel), and reversing detrimental obesity-related metabolic effects. These findings lay the foundation for further investigations of IER as an EC prevention and treatment strategies in overweight/obesity women.
引用
- Zhao Z, Wang J, Kong W, et al. Intermittent energy restriction inhibits tumor growth and enhances paclitaxel response in a transgenic mouse model of endometrial cancer. Gynecol Oncol. 2024. PMID: 38669767. doi:10.1016/j.ygyno.2024.04.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。